(TNS) -- Always looking for big ideas that can revolutionize industries, venture capitalists are starting to look beyond the overcrowded field of software startups. Some say their latest target could be more meaningful — and lucrative — than any app: biotechnology.
Silicon Valley’s biggest venture capitalists continue to pump massive late-round investments into established apps like Uber and Airbnb, but smaller biotech startups are increasingly piquing their interest and opening their wallets.
Image: FLICKR/BILL DICKINSON
